Anti-Phospholipid Antibodies and Coronavirus Disease 2019: Vaccination Does Not Trigger Early Autoantibody Production in Healthcare Workers

A molecular mimicry between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and human proteins supports the possibility that autoimmunity takes place during coronavirus disease 2019 (COVID-19) contributing to tissue damage. For example, anti-phospholipid antibodies (aPL) have been repor...

Полное описание

Библиографические подробности

Главные авторы:	Maria Orietta Borghi, Mauro Bombaci, Caterina Bodio, Paola Adele Lonati, Andrea Gobbini, Mariangela Lorenzo, Erminio Torresani, Antonella Dubini, Ilaria Bulgarelli, Francesca Solari, Francesca Pregnolato, Alessandra Bandera, Andrea Gori, Gianfranco Parati, Sergio Abrignani, Renata Grifantini, Pier Luigi Meroni
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Frontiers Media S.A. 2022-07-01
Серии:	Frontiers in Immunology
Предметы:	anti-phospholipid antibodies SARS-CoV-2 vaccination autoimmunity autoantibodies COVID-19
Online-ссылка:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.930074/full
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!